Posted on

Managing diabetes after incarceration: A difficult journey

For the average adult, a diabetes diagnosis is life-changing. Managing diabetes involves a daily routine that shifts toward remembering to take medication, check blood sugar, and monitor carbohydrate intake. Frequent trips to multiple doctors’ offices become the norm, as regular foot checks, dental appointments, eye exams, and primary care visits are crucial for avoiding the …

Continue reading “Managing diabetes after incarceration: A difficult journey”

Posted on

How do COVID-19 vaccines compare with other existing vaccines?

The novelty of the COVID-19 vaccines may seem daunting for some, and it is natural for questions to arise on their effectiveness. In this feature, we examine the difference between effectiveness and efficacy, compare the COVID-19 frontrunner vaccines to other vaccines, such as the flu shot, and compare their safety considerations. As Pfizer/BioNTech roll out …

Continue reading “How do COVID-19 vaccines compare with other existing vaccines?”

Posted on

Artificial pancreas effectively controls type 1 diabetes in children age 6 and up

A clinical trial at four pediatric diabetes centers in the United States has found that a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — is safe and effective at managing blood glucose levels in children as young as age six with type 1 diabetes. The trial was funded by …

Continue reading “Artificial pancreas effectively controls type 1 diabetes in children age 6 and up”

Posted on

Drug Might Relieve Low Back Pain in Whole New Way

A new nonopioid pain reliever could be welcome news for people who have difficult-to-treat back pain. Tanezumab is what’s called a monoclonal antibody. And it might offer extended relief from chronic lower back pain, a large, new study finds. However, a serious side effect remains a concern. Tanezumab works differently from other treatments, as it …

Continue reading “Drug Might Relieve Low Back Pain in Whole New Way”

Posted on

China coronavirus vaccine may be ready for public in November: official

Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Center for Disease Control and Prevention (CDC) said. China has four COVID-19 vaccines in the final stage of clinical trials. At least three of those have already been offered to essential …

Continue reading “China coronavirus vaccine may be ready for public in November: official”